Nearly 15% of King County children received MMRV as their first measles- or varicella-containing vaccine between 2015 and 2025, a share that did not change despite ACIP's longstanding preference for ...
THRIVE is the first phase 2 study to evaluate the VIASKIN Peanut Patch in infants aged 6 to 12 months with peanut allergy. Investigators will assess whether early epicutaneous immunotherapy can enable ...
THRIVE is the first study to evaluate the VIASKIN Peanut Patch in infants aged 6 to 12 months with confirmed peanut allergy. Investigators hope intervention during infancy may alter the long-term ...
Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, and Attending Physician, Pediatric Emergency Medicine, Nemours/Alfred I duPont ...